TNF and myeloid sarcoma: On the one hand, A1R activation in monocytoid cells triggered inhibition of TNF-α expression (11) and activation of A1R by its agonist R-phenylisopropyladenosine (R-PIA) was shown to block the secretion of IL-6 from PBMCs from MS patients (8).